INTRAMEDULLARY SPINAL HIGH GRADE GLIOMA WITH ALK FUSION AND EXCELLENT RESPONSE TO TARGETED TREATMENT WITH ALECTINIB: CASE REPORT

被引：0
|
作者：
Dvir, Rina [1 ]
Ringel, Amit [1 ]
Elhasid, Ronit [1 ]
Constantini, Shlomi [2 ]
Roth, Jonathan [2 ]
机构：
[1] Tel Aviv Sourasky Med Ctr, Pediat Hematooncol Dept, Tel Aviv, Israel
[2] Tel Aviv Sourasky Med Ctr, Pediat Neurosurg Dept, Tel Aviv, Israel
来源：
NEURO-ONCOLOGY | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
HGG-04
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [1] Significant response to targeted treatment with alectinib for intramedullary pediatric spinal high-grade glioma with ALK fusion
    Ringel, Amit
    Elhasid, Ronit
    Constantini, Shlomi
    Roth, Jonathan
    Dvir, Rina
    [J]. PEDIATRIC BLOOD & CANCER, 2023, 70 (07)
  • [2] STRN-ALK Fusion in Lung Adenocarcinoma with Excellent Response Upon Alectinib Treatment: A Case Report and Literature Review
    Su, Cuiyun
    Jiang, Ya
    Jiang, Wei
    Wang, Huilin
    Liu, Sisi
    Shao, Yang
    Zhao, Wenhua
    Ning, Ruiling
    Yu, Qitao
    [J]. ONCOTARGETS AND THERAPY, 2020, 13 : 12515 - 12519
  • [3] LORLATINIB FOR THE TREATMENT OF ALK FUSION POSITIVE INFANT HIGH GRADE GLIOMA
    Greenwell, Alyssa
    Altinok, Deniz
    Marupudi, Neena
    Kupsky, William
    Gorsi, Hamza
    [J]. NEURO-ONCOLOGY, 2022, 24 : 61 - 61
  • [4] Exceptional response to alectinib for duodenal carcinoma with ALK fusion: A case report and literature review
    Isaka, Yuri
    Sasaki, Akinori
    Saito, Akira
    Motomura, Yasuaki
    Ando, Yayoi
    Nakamura, Yoshiaki
    [J]. FRONTIERS IN ONCOLOGY, 2023, 12
  • [5] SDK1-ALK Fusion in a Lung Adenocarcinoma Patient With Excellent Response to ALK Inhibitor Treatment: A Case Report
    Ma, Lin
    Xiao, Junjuan
    Guan, Yaping
    Wu, Dongfang
    Gu, Tiantian
    Wang, Jun
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] Primary Intramedullary Spinal High-Grade Glioma: A Case Series with Review of Literature
    Aashita, Aashita
    Sharma, Rajiv
    Yadav, Vikas
    Manikandan, Muthu
    Dhameliya, Ankit
    Mishra, Hemendra
    Thakur, Pragyat
    Malik, Abhidha
    [J]. SOUTH ASIAN JOURNAL OF CANCER, 2024, 13 (02) : 150 - 156
  • [7] Response of a Novel KANK1::ALK Fusion to Alectinib in an Advanced Lung Adenocarcinoma: A Case Report
    Tang, Quanying
    Li, Tong
    Ren, Fan
    Li, Xuanguang
    Cao, WeiBo
    Yu, Haochuan
    Mao, Fuling
    Cao, Cancan
    Zu, Lingling
    Xu, Song
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (02):
  • [8] Remarkable response to alectinib for metastatic papillary thyroid cancer with STRN-ALK fusion: A case report
    Zhu, Lucheng
    Ma, Shenglin
    Xia, Bing
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] HIGH-Grade Glioma with a Novel VCL-ALK Fusion
    Yamamoto, Shunsuke
    Koga, Yuhki
    Asai, Hiroshi
    Goto, Hironori
    Ono, Hiroaki
    Hata, Nobuhiro
    Mizoguchi, Masahiro
    Yamamoto, Hidetaka
    Suzuki, Satoshi
    Ohga, Shouichi
    [J]. PEDIATRIC BLOOD & CANCER, 2020, 67
  • [10] Colorectal Cancer with EML4-ALK Fusion Gene Response to Alectinib: A Case Report and Review of the Literature
    Hsiao, Sheng-Yen
    He, Hong-Lin
    Weng, Teng-Song
    Lin, Cheng-Yao
    Chao, Chien-Ming
    Huang, Wen-Tsung
    Tsao, Chao-Jung
    [J]. CASE REPORTS IN ONCOLOGY, 2021, 14 (01): : 232 - 238
12345